{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:51:44Z","timestamp":1791431504897,"version":"4.3.3"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["15\/102\/04"],"award-info":[{"award-number":["15\/102\/04"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jval.2025.07.030","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:55:36Z","timestamp":1755554136000},"page":"54-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Cost-Effectiveness of Collagenase Injection Versus Limited Fasciectomy for Moderate Dupuytren\u2019s Contracture: An Economic Evaluation of the Dupuytren\u2019s Interventions Surgery Versus Collagenase Trial and a Decision Analytical Model"],"prefix":"10.1016","volume":"29","author":[{"given":"Qi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Arundel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puvanendran","family":"Tharmanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Corbacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Armaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bainbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Craigen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Flett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Keding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Knowlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Leighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Torgerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Warwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jval.2025.07.030_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/03008207.2011.642035","article-title":"Fibroproliferative disorders and their mechanobiology","volume":"53","author":"Huang","year":"2012","journal-title":"Connect Tissue Res"},{"issue":"1","key":"10.1016\/j.jval.2025.07.030_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5435\/00124635-199801000-00003","article-title":"Dupuytren\u2019s contracture","volume":"6","author":"Benson","year":"1998","journal-title":"J Am Acad Orthop Surg"},{"issue":"3","key":"10.1016\/j.jval.2025.07.030_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0895-4356(99)00145-6","article-title":"Epidemiology of Dupuytren\u2019s disease: clinical, serological, and social assessment. The Reykjavik study","volume":"53","author":"Gudmundsson","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jval.2025.07.030_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2474-12-73","article-title":"Dupuytren\u2019s contracture: a retrospective database analysis to assess clinical management and costs in England","volume":"12","author":"Gerber","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jval.2025.07.030_bib5","series-title":"Dupuytren Disease and Related Diseases-The Cutting Edge","first-page":"11","article-title":"The epidemiology of surgical intervention for Dupuytren contracture in England","author":"Dias","year":"2017"},{"issue":"12","key":"10.1016\/j.jval.2025.07.030_bib6","first-page":"CD010143","article-title":"Surgery for Dupuytren\u2019s contracture of the fingers","volume":"2015","author":"Rodrigues","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.jval.2025.07.030_bib7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase Clostridium histolyticum for Dupuytren\u2019s contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jval.2025.07.030_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhsa.2012.09.028","article-title":"Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS study): 3-year data","volume":"38","author":"Peimer","year":"2013","journal-title":"J Hand Surg"},{"issue":"4","key":"10.1016\/j.jval.2025.07.030_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/2292550320963111","volume":"29","author":"Fitzpatrick","year":"2021","journal-title":"Plast Surg (Oakv)"},{"issue":"1","key":"10.1016\/j.jval.2025.07.030_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bmb\/ldw020","article-title":"Collagenase Clostridium histolyticum in Dupuytren\u2019s contracture: a systematic review","volume":"118","author":"Smeraglia","year":"2016","journal-title":"Br Med Bull"},{"issue":"8","key":"10.1016\/j.jval.2025.07.030_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000004480","article-title":"Real-world medicare healthcare costs of patients with Dupuytren\u2019s contracture treated with collagenase or fasciectomy","volume":"10","author":"Zah","year":"2022","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"1","key":"10.1016\/j.jval.2025.07.030_bib13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1186\/s13063-021-05595-w","article-title":"Dupuytren\u2019s interventions surgery versus collagenase (DISC) trial: study protocol for a pragmatic, two-arm parallel-group, non-inferiority randomised controlled trial","volume":"22","author":"Dias","year":"2021","journal-title":"Trials"},{"issue":"16","key":"10.1016\/j.jval.2025.07.030_bib14","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa2312631","article-title":"Collagenase Injection versus Limited Fasciectomy for Dupuytren\u2019s contracture","volume":"391","author":"Dias","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jval.2025.07.030_bib18","author":"Curtis"},{"issue":"1","key":"10.1016\/j.jval.2025.07.030_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13561-020-0260-8","article-title":"The use of micro-costing in economic analyses of surgical interventions: a systematic review","volume":"10","author":"Potter","year":"2020","journal-title":"Health Econ Rev"},{"issue":"3","key":"10.1016\/j.jval.2025.07.030_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bjps.2013.12.030","article-title":"A single-centre cost comparison analysis of collagenase injection versus surgical fasciectomy for Dupuytren\u2019s contracture of the hand","volume":"67","author":"Mehta","year":"2014","journal-title":"J Plast Reconstr Aesthetic Surg"},{"issue":"2","key":"10.1016\/j.jval.2025.07.030_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40273-022-01218-7","article-title":"Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from a UK population study","volume":"41","author":"Hernandez Alava","year":"2023","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"10.1016\/j.jval.2025.07.030_bib27","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hec.901","article-title":"Calculation of quality adjusted life years in the published literature: a review of methodology and transparency","volume":"13","author":"Richardson","year":"2004","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2025.07.030_bib28","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"issue":"5","key":"10.1016\/j.jval.2025.07.030_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hec.843","article-title":"Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data","volume":"13","author":"Willan","year":"2004","journal-title":"Health Econ"},{"issue":"12","key":"10.1016\/j.jval.2025.07.030_bib30","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","article-title":"A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials","volume":"32","author":"Faria","year":"2014","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.jval.2025.07.030_bib31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hec.944","article-title":"Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility","volume":"14","author":"Manca","year":"2005","journal-title":"Health Econ"},{"issue":"4","key":"10.1016\/j.jval.2025.07.030_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W","article-title":"Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation","volume":"6","author":"Briggs","year":"1997","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2025.07.030_bib33","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"issue":"4","key":"10.1016\/j.jval.2025.07.030_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"11","key":"10.1016\/j.jval.2025.07.030_bib38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"issue":"12","key":"10.1016\/j.jval.2025.07.030_bib35","article-title":"Cost-effectiveness and patient outcomes of injectable collagenase to treat Dupuytren\u2019s contracture","volume":"13","author":"Sahemey","year":"2021","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.jval.2025.07.030_bib36","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1302\/0301-620X.102B10.BJJ-2019-1685.R2","article-title":"Fasciectomy under local anaesthetic and adrenaline for Dupuytren\u2019s contracture in a community setting in the UK with a cost analysis","volume":"102-B","author":"Noureddine","year":"2020","journal-title":"Bone Joint J"},{"issue":"5","key":"10.1016\/j.jval.2025.07.030_bib37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/15589447211072251","article-title":"Initial treatment choice affects cost-effectiveness and reintervention rates for Dupuytren contracture: a national census among Veterans Affairs patients","volume":"18","author":"Drinane","year":"2023","journal-title":"Hand (N Y)"},{"issue":"3","key":"10.1016\/j.jval.2025.07.030_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/PRS.0000000000008224","article-title":"Return to work and associated costs after treatment for Dupuytren\u2019s disease","volume":"148","author":"Blake","year":"2021","journal-title":"Plast Reconstr Surg"},{"issue":"90","key":"10.1016\/j.jval.2025.07.030_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19900","article-title":"Collagenase clostridium histolyticum for the treatment of Dupuytren\u2019s contracture: systematic review and economic evaluation","volume":"19","author":"Brazzelli","year":"2015","journal-title":"Health Technol Assess"},{"issue":"10","key":"10.1016\/j.jval.2025.07.030_bib41","article-title":"Cost-effectiveness of recurrent Dupuytren contracture treatment","volume":"3","author":"Yoon","year":"2020","journal-title":"JAMA Netw"},{"issue":"8","key":"10.1016\/j.jval.2025.07.030_bib42","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jhsa.2015.04.036","article-title":"Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-year data","volume":"40","author":"Peimer","year":"2015","journal-title":"J Hand Surg"},{"issue":"5","key":"10.1016\/j.jval.2025.07.030_bib43","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/J.JHSB.2006.05.005","article-title":"Dupuytren\u2019s contracture: an audit of the outcomes of surgery","volume":"31","author":"Dias","year":"2006","journal-title":"J Hand Surg, Br Eur Volume"},{"issue":"10","key":"10.1016\/j.jval.2025.07.030_bib44","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jhsa.2013.05.038","article-title":"Patterns of recontracture after surgical correction of Dupuytrens disease","volume":"38","author":"Dias","year":"2013","journal-title":"J Hand Surg Am"},{"issue":"1","key":"10.1016\/j.jval.2025.07.030_bib45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0272989X9401400107","article-title":"Determining transition probabilities: confusion and suggestions","volume":"14","author":"Miller","year":"1994","journal-title":"Med Decis Mak"},{"issue":"4","key":"10.1016\/j.jval.2025.07.030_bib46","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Mak"},{"issue":"5","key":"10.1016\/j.jval.2025.07.030_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhsa.2017.03.003","article-title":"Injectable collagenase versus percutaneous needle fasciotomy for Dupuytren contracture in proximal interphalangeal joints: a randomized controlled trial","volume":"42","author":"Skov","year":"2017","journal-title":"J Hand Surg Am"},{"issue":"2","key":"10.1016\/j.jval.2025.07.030_bib48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/PRS.0b013e31823aea95","article-title":"Five-year Results of a Randomized Clinical Trial on Treatment in Dupuytren\u2019s Disease: percutaneous needle fasciotomy versus limited fasciectomy","volume":"129","author":"van Rijssen","year":"2012","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.jval.2025.07.030_bib50","first-page":"642","article-title":"A 10-year review of collagenase versus fasciectomy in the treatment of Dupuytren contracture","volume":"92","author":"Steppe","year":"2024","journal-title":"Ann Plast Surg"},{"issue":"10","key":"10.1016\/j.jval.2025.07.030_bib51","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jhsa.2021.05.022","article-title":"Limited fasciectomy versus collagenase Clostridium histolyticum for Dupuytren contracture: a propensity score matched study of single digit treatment with minimum 5 years of telephone follow-up","volume":"46","author":"Gruber","year":"2021","journal-title":"J Hand Surg Am"},{"key":"10.1016\/j.jval.2025.07.030_bib52","series-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"issue":"3","key":"10.1016\/j.jval.2025.07.030_bib53","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PRS.0000000000009919","article-title":"Dupuytren disease: prevalence, incidence, and lifetime risk of surgical intervention. A population-based cohort analysis","volume":"151","author":"Broekstra","year":"2023","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.jval.2025.07.030_bib54","doi-asserted-by":"crossref","first-page":"618e","DOI":"10.1097\/PRS.0000000000011854","article-title":"Update on Dupuytren disease: pathogenesis, natural history, treatment, and outcomes","volume":"155","author":"Ohmes","year":"2025","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.jval.2025.07.030_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/17531934221131373","article-title":"Treatments for early-stage Dupuytren\u2019s disease: an evidence-based approach","volume":"48","author":"Nanchahal","year":"2023","journal-title":"J Hand Surg Eur"},{"issue":"9","key":"10.1016\/j.jval.2025.07.030_bib56","doi-asserted-by":"crossref","first-page":"662","DOI":"10.7326\/0003-4819-151-9-200911030-00011","article-title":"Much cheaper, almost as good: decrementally cost-effective medical innovation","volume":"151","author":"Nelson","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2025.07.030_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1025326","article-title":"Decrementally cost-effective health technologies in non-inferiority studies: a systematic review","volume":"13","author":"Darlington","year":"2022","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.jval.2025.07.030_bib58","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1177\/1558944721994220","article-title":"Outcomes of management of recurrent Dupuytren contracture: a systematic review and meta-analysis","volume":"17","author":"Wong","year":"2022","journal-title":"Hand (N Y)"},{"issue":"1","key":"10.1016\/j.jval.2025.07.030_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004166","article-title":"Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study","volume":"4","author":"Atroshi","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jval.2025.07.030_bib60","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2147\/CEOR.S269957","article-title":"Healthcare costs and resource use of patients with Dupuytren contracture treated with collagenase Clostridium histolyticum or fasciectomy: A propensity matching analysis","volume":"12","author":"Zah","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"issue":"1","key":"10.1016\/j.jval.2025.07.030_bib61","first-page":"24","article-title":"Costs of collagenase Clostridium histolyticum and fasciectomy for Dupuytren\u2019s contracture","volume":"7","author":"Donga","year":"2015","journal-title":"Am J Pharm Ben"},{"issue":"1","key":"10.1016\/j.jval.2025.07.030_bib62","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1038\/s41598-022-12966-z","article-title":"The CeCORD-J study on collagenase injection versus aponeurectomy for Dupuytren\u2019s contracture compared by hand function and cost effectiveness","volume":"12","author":"Yamamoto","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jval.2025.07.030_bib63","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.jval.2011.02.714","article-title":"PMS29 Cost-utility analysis of collagenase Clostridium histolyticum, limited fasciectomy, and percutaneous needle fasciotomy in Dupuytren\u2019s contracture","volume":"14","author":"Sau","year":"2011","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.jval.2025.07.030_bib65","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jhsa.2013.03.036","article-title":"The impact of Dupuytren disease on patient activity and quality of life","volume":"38","author":"Wilburn","year":"2013","journal-title":"J Hand Surg Am"},{"issue":"8","key":"10.1016\/j.jval.2025.07.030_bib66","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1302\/0301-620X.95B8.31822","article-title":"Cost-effectiveness in the management of Dupuytren\u2019s contracture. A Canadian cost-utility analysis of current and future management strategies","volume":"95-B","author":"Baltzer","year":"2013","journal-title":"Bone Joint J"},{"issue":"11","key":"10.1016\/j.jval.2025.07.030_bib67","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.jhsa.2011.08.004","article-title":"Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for Dupuytren contracture","volume":"36","author":"Chen","year":"2011","journal-title":"J Hand Surg Am"},{"issue":"2","key":"10.1016\/j.jval.2025.07.030_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhsg.2018.12.005","article-title":"Cost per episode of care with collagenase Clostridium histolyticum versus fasciectomy for Dupuytren contracture: a real-world claims database analysis","volume":"1","author":"Camper","year":"2019","journal-title":"J Hand Surg Glob Online"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525025161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525025161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:06:23Z","timestamp":1791428783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525025161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1098301525025161"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.07.030","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cost-Effectiveness of Collagenase Injection Versus Limited Fasciectomy for Moderate Dupuytren\u2019s Contracture: An Economic Evaluation of the Dupuytren\u2019s Interventions Surgery Versus Collagenase Trial and a Decision Analytical Model","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}